Belpointe Asset Management LLC Takes $690,000 Position in Oscar Health, Inc. $OSCR

Belpointe Asset Management LLC bought a new stake in Oscar Health, Inc. (NYSE:OSCR) during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 32,161 shares of the company’s stock, valued at approximately $690,000.

Several other institutional investors have also modified their holdings of OSCR. Hsbc Holdings PLC boosted its position in Oscar Health by 2.7% during the first quarter. Hsbc Holdings PLC now owns 24,113 shares of the company’s stock worth $313,000 after acquiring an additional 632 shares during the last quarter. Tempus Wealth Planning LLC boosted its position in Oscar Health by 6.7% during the first quarter. Tempus Wealth Planning LLC now owns 14,392 shares of the company’s stock worth $189,000 after acquiring an additional 906 shares during the last quarter. Focus Partners Wealth boosted its position in Oscar Health by 1.8% during the first quarter. Focus Partners Wealth now owns 55,158 shares of the company’s stock worth $723,000 after acquiring an additional 949 shares during the last quarter. Xponance Inc. raised its stake in Oscar Health by 7.1% during the first quarter. Xponance Inc. now owns 15,423 shares of the company’s stock worth $202,000 after purchasing an additional 1,029 shares during the period. Finally, CWM LLC raised its stake in Oscar Health by 50.7% during the first quarter. CWM LLC now owns 3,204 shares of the company’s stock worth $42,000 after purchasing an additional 1,078 shares during the period. Institutional investors and hedge funds own 75.70% of the company’s stock.

Insiders Place Their Bets

In related news, insider Mario Schlosser sold 395,000 shares of the company’s stock in a transaction that occurred on Monday, September 22nd. The shares were sold at an average price of $18.43, for a total transaction of $7,279,850.00. Following the sale, the insider directly owned 501,148 shares of the company’s stock, valued at $9,236,157.64. This represents a 44.08% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 24.39% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

A number of brokerages have commented on OSCR. Piper Sandler reduced their target price on shares of Oscar Health from $14.00 to $13.00 and set a “neutral” rating on the stock in a research note on Thursday, August 14th. Wells Fargo & Company lifted their target price on shares of Oscar Health from $10.00 to $14.00 and gave the stock an “underweight” rating in a research note on Tuesday. UBS Group reaffirmed a “sell” rating and set a $11.00 target price (down from $15.00) on shares of Oscar Health in a research note on Tuesday, July 15th. Raymond James Financial downgraded shares of Oscar Health from an “outperform” rating to a “market perform” rating in a research note on Tuesday, June 24th. Finally, Baird R W downgraded shares of Oscar Health from a “strong-buy” rating to a “hold” rating in a research note on Friday, July 25th. Four investment analysts have rated the stock with a Hold rating and six have given a Sell rating to the stock. According to MarketBeat, the company currently has an average rating of “Strong Sell” and a consensus price target of $12.64.

Oscar Health Price Performance

Oscar Health stock opened at $21.79 on Thursday. The company’s 50 day simple moving average is $17.54 and its 200-day simple moving average is $15.77. The company has a market capitalization of $5.63 billion, a price-to-earnings ratio of -26.90 and a beta of 1.89. Oscar Health, Inc. has a 1 year low of $11.20 and a 1 year high of $23.80. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.86 and a current ratio of 0.86.

Oscar Health (NYSE:OSCR) last released its quarterly earnings results on Wednesday, August 6th. The company reported ($0.89) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.90) by $0.01. The business had revenue of $2.86 billion for the quarter, compared to the consensus estimate of $2.88 billion. Oscar Health had a negative net margin of 1.50% and a negative return on equity of 13.78%. The business’s revenue was up 29.0% on a year-over-year basis. During the same period in the previous year, the firm earned $0.20 EPS. As a group, equities research analysts expect that Oscar Health, Inc. will post 0.69 earnings per share for the current year.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.